Detalhe da pesquisa
1.
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study.
Antimicrob Agents Chemother
; 67(3): e0151422, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852998